Recurrent urinary tract infection associated with SGLT-2 inhibitor in type 2 diabetes mellitus patient: A case report.

Mohammad HaziqueArihant SuranaMehul SinhaAyush Anand

Published in: Clinical case reports (2023)

A high index of clinical suspicion of urinary tract infections due to empagliflozin use should be maintained in T2DM patients to avoid progression to life-threatening condition.

Keyphrases

urinary tract infection
end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
patient reported
skeletal muscle